ITMCTR2200006570尚未招募1 期
Clinical trial of Modified Shenling Baizhu Powder in the treatment of spleen deficiency and dampness turbidity syndrome of chronic nephritis
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •a) Diagnosed as chronic nephritis;
- •b) TCM syndrome differentiation belongs to spleen and kidney qi deficiency and dampness turbidity syndrome;
- •c) Age 18 ~ 65 years old;
- •d) The 24-hour urinary protein content is 0.5g ~ 3g;
- •e) eGFR>60 ml/(min·1.73m2)
排除标准
- •a) Except purpura nephritis, lupus nephritis and other secondary glomerular diseases;
- •b) Pregnant and lactating women;
- •c) Complicated with serious mental disorders or serious cardiovascular, cerebrovascular and liver diseases.
研究者
相似试验
尚未招募
1 期
Clinical study of Shenling Baizhu Powder combined with Special Disease Prescription in the treatment of ulcerative colitis with dampness obstruction syndrome of spleen deficiencyulcerative colitisITMCTR2200006064Guangdong Provincial Hospital of Traditional Chinese Medicine
尚未招募
不适用
Modified Shenling Baizhu Powder in the Treatment of Ulcerative Colitis in the Remission Phase: a Series of N-of-1 Randomized, Controlled Trialslcerative ColitisITMCTR2100005038The First Affiliated Hospital of Guangzhou University of Chinese Medicine
招募中
1 期
Effects of Shenlingbaizhu powder on the efficacy of chemotherapy and the quality of life of patients with ovarian cancer based on intestinal microecologyOvarian cancerITMCTR2100004792The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
招募中
1 期
Clinical Trial of Chinese Medicine in the Treatment of Cough Variant AsthmaCough variant asthmaITMCTR2000002990Oriental Hospital of Beijing University of Traditional Chinese Medicine
招募中
不适用
Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19)ITMCTR2000003225nion Hospital of Tongji Medical College, Huazhong University of Science and Technology